Alerus Investment Advisors’s AbbVie ABBV Stock Holding History

Alerus Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.54M	Buy	26,958 +15,273	+131%	+$851K	0.27%	83
2015 Q4	$693K	Buy	+11,685	New	+$673K	0.12%	103
2014 Q3	–	Sell	-394	Closed	-$22K	–	152
2014 Q2	$22K	Hold	394	–	–	﹤0.01%	144
2014 Q1	$20K	Hold	394	–	–	﹤0.01%	144
2013 Q4	$19K	Sell	394 -8,629	-96%	-$424K	﹤0.01%	143
2013 Q3	$406K	Sell	9,023 -2,777	-24%	-$123K	0.08%	107
2013 Q2	$490K	Buy	+11,800	New	+$516K	0.08%	109

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alerus Investment Advisors's ABBV Position: Q1 2016 in Review

Alerus Investment Advisors increased its AbbVie (ABBV) stake by 131% in Q1 2016, buying an estimated $851K and bringing the position to 26,958 shares worth $1.54M. The position accounts for 0.27% of the portfolio, ranked #83.

Alerus Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Alerus Investment Advisors held 26,958 shares of AbbVie worth $1.54M as of Q1 2016.
Alerus Investment Advisors bought 15,273 AbbVie shares in Q1 2016, an estimated $851K.
AbbVie made up 0.27% of Alerus Investment Advisors's portfolio in Q1 2016, its #83 holding.
Alerus Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.